Oxford BioDynamics Plc

Informe acción AIM:OBD

Capitalización de mercado: UK£3.7m

Oxford BioDynamics Crecimiento futuro

Future controles de criterios 2/6

Oxford BioDynamics's earnings are forecast to decline at 4.5% per annum while its annual revenue is expected to grow at 85.3% per year. EPS is expected to grow by 32.1% per annum.

Información clave

-4.5%

Tasa de crecimiento de los beneficios

32.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Life Sciences19.8%
Tasa de crecimiento de los ingresos85.3%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualización18 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Here's Why We're Watching Oxford BioDynamics' (LON:OBD) Cash Burn Situation

Jan 18
Here's Why We're Watching Oxford BioDynamics' (LON:OBD) Cash Burn Situation

Here's Why We're A Bit Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Situation

Oct 08
Here's Why We're A Bit Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Situation

Is Oxford BioDynamics (LON:OBD) In A Good Position To Invest In Growth?

Sep 21
Is Oxford BioDynamics (LON:OBD) In A Good Position To Invest In Growth?

Oxford BioDynamics (LON:OBD) Is In A Good Position To Deliver On Growth Plans

May 24
Oxford BioDynamics (LON:OBD) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Rate

Dec 07
We're Not Very Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Rate

Previsiones de crecimiento de beneficios e ingresos

AIM:OBD - Estimaciones futuras de los analistas y datos financieros pasados (GBP Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
9/30/20252-12N/A-101
9/30/20241-11N/A-101
3/31/20241-11-7-7N/A
12/31/20231-11-8-7N/A
9/30/20231-11-9-8N/A
6/30/20230-10-9-8N/A
3/31/20230-8-9-8N/A
12/31/20220-7-7-7N/A
9/30/20220-7-6-5N/A
6/30/20220-7-7-5N/A
3/31/20220-6-9-5N/A
12/31/20210-7-9-6N/A
9/30/20210-7-9-6N/A
6/30/20210-6-7-5N/A
3/31/20211-5-6-5N/A
12/31/20200-5-5-4N/A
9/30/20200-4-4-3N/A
6/30/20200-4-4-3N/A
3/31/20201-4-3-3N/A
12/31/20191-3-3-3N/A
9/30/20191-3-3-2N/A
6/30/20191-2-3-2N/A
3/31/20191-2-3-2N/A
12/31/20181-2-3-2N/A
9/30/20181-2-3-2N/A
6/30/20181-2-2-2N/A
3/31/20181-2-2-1N/A
12/31/20171-3N/A-1N/A
9/30/20171-4N/A-2N/A
6/30/20171-4N/A-1N/A
3/31/20171-4N/A-1N/A
12/31/20161-3N/A-1N/A
9/30/20161-2N/A-1N/A
6/30/20161-2N/A-2N/A
3/31/20161-1N/A-2N/A
12/31/20151-1N/A-2N/A
9/30/20151-1N/A-1N/A
9/30/20141-1N/A0N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: OBD is forecast to remain unprofitable over the next 3 years.

Beneficios vs. Mercado: OBD is forecast to remain unprofitable over the next 3 years.

Beneficios de alto crecimiento: OBD is forecast to remain unprofitable over the next 3 years.

Ingresos vs. Mercado: OBD's revenue (85.3% per year) is forecast to grow faster than the UK market (3.6% per year).

Ingresos de alto crecimiento: OBD's revenue (85.3% per year) is forecast to grow faster than 20% per year.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Insufficient data to determine if OBD's Return on Equity is forecast to be high in 3 years time


Descubre empresas en crecimiento